Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardio Diagnostics Holdings (CDIO) Cash from Financing Activities (2021 - 2025)

Historic Cash from Financing Activities for Cardio Diagnostics Holdings (CDIO) over the last 5 years, with Q3 2025 value amounting to $39955.0.

  • Cardio Diagnostics Holdings' Cash from Financing Activities fell 9790.64% to $39955.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $10.5 million, marking a year-over-year increase of 13102.68%. This contributed to the annual value of $11.9 million for FY2024, which is 22873.68% up from last year.
  • As of Q3 2025, Cardio Diagnostics Holdings' Cash from Financing Activities stood at $39955.0, which was down 9790.64% from -$115037.0 recorded in Q2 2025.
  • Cardio Diagnostics Holdings' 5-year Cash from Financing Activities high stood at $65.8 million for Q4 2021, and its period low was -$1.7 million during Q4 2022.
  • In the last 5 years, Cardio Diagnostics Holdings' Cash from Financing Activities had a median value of $1.0 million in 2022 and averaged $5.5 million.
  • Per our database at Business Quant, Cardio Diagnostics Holdings' Cash from Financing Activities skyrocketed by 2841599.12% in 2022 and then tumbled by 12772.7% in 2023.
  • Cardio Diagnostics Holdings' Cash from Financing Activities (Quarter) stood at $65.8 million in 2021, then plummeted by 102.62% to -$1.7 million in 2022, then surged by 94.58% to -$93500.0 in 2023, then skyrocketed by 7898.72% to $7.3 million in 2024, then tumbled by 99.45% to $39955.0 in 2025.
  • Its Cash from Financing Activities was $39955.0 in Q3 2025, compared to -$115037.0 in Q2 2025 and $3.3 million in Q1 2025.